Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)
Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The goal of this research is to determine the utility of Regadenoson (Lexiscan)for use as an
imaging agent with cardiac MR. If found useful, it will help us establish a protocol for
regadenoson stress MR perfusion (Regadenoson stress test with cardiac MR).The investigators
will compare regadenoson with dobutamine so each participant will undergo two studies. A
cardiac MR stress test with regadenoson and with dobutamine. The investigators participants
will include patients with history of COPD and Asthma, so it will also help us determine
feasibility of Regadenoson in these patient's subgroups.
Phase:
Early Phase 1
Details
Lead Sponsor:
Wake Forest Baptist Health Wake Forest University Health Sciences